CONTENTS:
- N, N-Dimethyltryptamine (DMT)-occasioned familiarity and the Sense of Familiarity Questionnaire (SOF-Q). Lawrence D.W., DiBattista A.P., Timmermann C., p. 443-455.
- Translation and initial psychometric evaluation of Spanish versions of three psychedelic acute effects measures: Mystical, challenging, and insight experiences. Davis A.K., Timmermann C., Ortiz Bernal A.M., Lancelotta R., Nayak S., Sepeda N.D., et al., p. 456-466.
- Seasonal variation of use of common psychedelics and party drugs among nightclub/festival attendees in New York City. Palamar J.J., Rutherford C., Le A., Keyes K.M., p. 467-474.
- On the mushrooming reports of "quiet quitting": Employees' lifetime psilocybin use predicts their overtime hours worked. Korman B.A., p. 475-484.
- A preliminary inventory of kratom (Mitragyna speciosa) products and vendors on the darknet and cryptomarkets. Prevete E., Catalani V., Singh D., Kuypers K.P.C., Theunissen E.L., Townshend H.D., et al., p. 485-495.
- Therapeutic protocols using ketamine and esketamine for depressive disorders: A systematic review. Freind J.M.K., Beserra F.R., Menezes B.S., Mograbi D.C., p. 496-512.
- Beyond psilocybin: Reviewing the therapeutic potential of other serotonergic psychedelics in mental and substance use disorders. Wong S., Yu A.Y., Fabiano N., Finkelstein O., Pasricha A., Jones B.D.M., et al., p. 513-529.
- Correlates of perceived discrimination related to substance use disorders among patients in methadone maintenance treatment. Nwanaji-Enwerem U., Beitel M., Oberleitner D.E., Gaeta Gazzola M., Eggert K.F., Oberleitner L.M.S., et al., p. 530-540.
- Depression and substance use among Brazilian university students during the COVID-19 pandemic. Camargo Junior E.B., Noivo I.S., Gouvea T.C.C., Fernandes M.N.F., Gherardi-Donato E., p. 541-550.
- Exploratory growth mixture modeling of cannabis-withdrawal syndrome trajectories of adult pure cannabis dependents during detoxification: Two subtypes? Claus B.B., Scherbaum N., Specka M., Roser P., Bonnet U., p. 551-562.
- THC-O-acetate: Scarce evidence for a psychedelic cannabinoid. Kruger D.J., Bone C.C., Meacham M.C., Klein C., Kruger J.S., p. 563-567.
- Survey of U.S. residents and their usage of electronic cigarettes with drugs other than nicotine. Holt A.K., Rudy A.K., Sawyer A.N., Poklis J.L., Breland A.B., Peace M.R., p. 568-577.
- Safety of alprazolam use in pregnancy in Western Australia: A retrospective cohort study using linked health data. Kelty E., Chitty K., Preen D.B., p. 578-584.
- Chemsex and harm reduction practices among men who have sex with men in Malaysia: Findings from a qualitative study. Palmer L., Maviglia F., Wickersham J.A., Khati A., Kennedy O., Copenhaver N.M., et al., p. 585-594.
- Methamphetamine-induced wakefulness and sleep management: A qualitative analysis of online narratives. Regmi S., Kedia S.K., Schmidt M., Mahmood A., Lugemwa T., Dillon P.J., p. 595-602.